Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia-warm reperfusion injury

Hepatology

Volumn 47, Issue 1, 2008, Pages 177-185

  Defamie, Virginie ^a   Laurens, Marina ^b,c   Patrono, Damiano ^c   Devel, Laurent ^d   Brault, Antoine ^e   Saint Paul, Marie Christine ^f   Yiotakis, Athanasios ^g   Barbry, Pascal ^a   Gugenheim, Jean ^c   Crenesse, Dominique ^b   Dive, Vincent ^d   Huet, Pierre Michel ^b,c   Mari, Bernard ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d CEA SACLAY   (France)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^f PASTEUR HOSPITAL   (France)

^g UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; GELATINASE; LIVER ENZYME; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PHOSPHINIC ACID DERIVATIVE; RXP 409; TRYPAN BLUE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; CELL DEATH; CELL ISOLATION; COLD ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ERYTHROCYTE; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; ISOLATED LIVER; LIVER BIOPSY; LIVER CELL; LIVER FUNCTION; LIVER INJURY; LIVER PERFUSION; LIVER PRESERVATION; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; COLD ISCHEMIA; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FIBRONECTINS; GENE EXPRESSION; HEPATOCYTES; LIVER DISEASES; MALE; MATRIX METALLOPROTEINASES; NECROSIS; PHOSPHINIC ACIDS; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TISSUE SURVIVAL; TRYPTOPHAN;

EID: 38649129385     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21929     Document Type: Article

References (38)

1. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000;32:508-515.
2. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003;125:1246-1257.
3. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79:1881-1894.
4. Marzi I, Zhong Z, Lemasters JJ, Thurman RG. Evidence that graft survival is not related to parenchymal cell viability in rat liver transplantation. The importance of nonparenchymal cells. Transplantation 1989;48:463-468.
5. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers. HEPATOLOGY 1989;10:292-299.
6. McKeown CM, Edwards V, Phillips MJ, Harvey PR, Petrunka CN, Strasberg SM. Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation 1988;46:178-191.
7. Holloway CM, Harvey PR, Strasberg SM. Viability of sinusoidal lining cells in cold-preserved rat liver allografts. Transplantation 1990;49:225-229.
8. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. HEPATOLOGY 1998;27:1652-1660.
9. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, et al. Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999;68:89-96.
10. Sutto F, Brault A, Lepage R, Huet PM. Metabolism of hyaluronic acid by liver endothelial cells: effect of ischemia-reperfusion in the isolated perfused rat liver. J Hepatol 1994;20:611-616.
11. Urata K, Nguyen B, Brault A, Lavoie J, Rocheleau B, Huet PM. Decreased survival in rat liver transplantation with extended cold preservation: role of portal vein clamping time. HEPATOLOGY 1998;28:366-373.
12. Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, et al. Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. HEPATOLOGY 2004;39:1110-1119.
13. Aguilar HI, Steers JL, Wiesner RH, Krom RA, Gores GJ. Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allografts. Transplantation 1997;63:612-614.
14. Calmus Y, Cynober L, Dousset B, Lim SK, Soubrane O, Conti F, et al. Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology 1995;108:1510-1516.
15. Upadhya AG, Harvey RP, Howard TK, Lowell JA, Shenoy S, Strasberg SM. Evidence of a role for matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. HEPATOLOGY 1997;26:922-928.
16. Upadhya GA, Strasberg SM. Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions. HEPATOLOGY 2000;31:1115-1122.
17. Kuyvenhoven JP, Ringers J, Verspaget HW, Lamers CB, van Hoek B. Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation. Transplant Proc 2003;35:2967-2969.
18. Kuyvenhoven JP, Verspaget HW, Gao Q, Ringers J, Smit VT, Lamers CB, et al. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 2004;77:1646-1652.
19. Cursio R, Mari B, Louis K, Rostagno P, Saint-Paul MC, Giudicelli J, et al. Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J 2002;16:93-95.
20. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29:1020-1030.
21. Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 2000;101:1833-1839.
22. Takei Y, Marzi I, Kauffman FC, Currin RT, Lemasters JJ, Thurman RG. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine. Transplantation 1990;50:14-20.
23. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E, et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003;278:11888-11896.
24. Devel L, Rogakos V, David A, Makaritis A, Beau F, Cuniasse P, et al. Development of selective inhibitors and substrate of matrix metalloproteinase- 12. J Biol Chem 2006;281:11152-11160.
25. Jacquel A, Herrant M, Defamie V, Belhacene N, Colosetti P, Marchetti S, et al. A survey of the signaling pathways involved in megakaryocyte differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 2006;25:781-794.
26. Arthur MJ, Friedman SL, Roll FJ, Bissell DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989;84:1076-1085.
27. Winwood PJ, Schuppan D, Iredale JP, Kawser CA, Docherty AJ, Arthur MJ. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: characterization and expression in cultured cells. HEPATOLOGY 1995;22:304-315.
28. Gao W, Washington MK, Bentley RC, Clavien PA. Antiangiogenic agents protect liver sinusoidal lining cells from cold preservation injury in rat liver transplantation. Gastroenterology 1997;113:1692-1700.
29. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-893.
30. Ben-Yosef Y, Miller A, Shapiro S, Lahat N. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol 2005;289:C1321-C1331.
31. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 2005;25:6401-6408.
32. Conant K, St Hillaire C, Nagase H, Visse R, Gary D, Haughey N, et al. Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt. J Biol Chem 2004;279:8056-8062.
33. Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002;277:47461-47468.
34. Pullan S, Wilson J, Metcalfe A, Edwards GM, Goberdhan N, Tilly J, et al. Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci 1996;109:631-642.
35. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999;9:1441-1447.
36. Ortega N, Behonick DJ, Colnot C, Cooper DN, Werb Z. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell 2005;16:3028-3039.
37. Dive V, Georgiadis D, Matziari M, Makaritis A, Beau F, Cuniasse P, et al. Phosphinic peptides as zinc metalloproteinase inhibitors. Cell Mol Life Sci 2004;61:2010-2019.
38. Arthur MJ. Matrix degradation in liver: a role in injury and repair. HEPATOLOGY 1997;26:1069-1071.